Evidence map›Paper›PMID 18648918›Full record

ReviewJournal of autism and developmental disorders2009

Pleiotropic effects of neurotransmission during development: modulators of modularity.

Barbara L Thompson, Gregg D Stanwood

Open access · greenAbstract readReview
In one paragraph

Review in Journal of autism and developmental disorders, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Barbara L ThompsonDepartment of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA. barbara.thompson@vanderbilt.edu
Gregg D Stanwood
Vanderbilt University · US

Funding

THREE-TIERED PREVENTION MODEL TO BETTER SERVE ALL STUDENP30HD015052 · NICHD · VANDERBILT UNIVERSITY · PI ANDERSON, ADAM W · 1985 to 2014
$18.6M
Developmental consequences of in utero cocaineF32DA020981 · NIDA · VANDERBILT UNIVERSITY · PI THOMPSON, BARBARA L · 2006 to 2008
$153k
NICHD NIH HHS P30 HD015052NICHD NIH HHS P30HD15052NIDA NIH HHS F32 DA020981NIDA NIH HHS F32DA020981
6 · The paper itself

Abstract

The formation and function of the mammalian cerebral cortex relies on the complex interplay of a variety of genetic and environmental factors through protracted periods of gestational and postnatal development. Biogenic amine systems are important neuromodulators, both in the adult nervous system, and during critical epochs of brain development. Abnormalities in developmental programming likely contribute to developmental delays and multiple neurological and psychiatric disorders, often with symptom onset much later than the actual induction of pathology. We review several genetic and pharmacological models of dopamine, norepinephrine and serotonin modulation during development, each of which produces permanent changes in cerebral cortical structure and function. These models clearly illustrate the ability of these neurotransmitters to function beyond their classic roles and show their involvement in the development and modulation of fine brain circuitry that is sensitive to numerous effectors. Furthermore, these studies demonstrate the need to consider not only gene by environment interactions, but also gene by environment by developmental time interactions.

Indexed as

AnimalsBrainCerebral CortexDopamineHumansNeuronsNeurotransmitter AgentsNorepinephrineSerotoninSynaptic TransmissionDopamineNeurotransmitter AgentsNorepinephrineSerotonin

Identifiers

PMID18648918
PMCPMC2777884
OpenAlexW2050802311

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.